| Utility: Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof Filling date: 8 Sep 2025 Issue date: 23 Aug 2022 | 22 Jun 2020 | 23 Aug 2022 |
| Utility: Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof Filling date: 8 Sep 2025 Issue date: 12 Jul 2022 | 15 May 2019 | 12 Jul 2022 |
| Utility: Covalent diabodies and uses thereof Filling date: 8 Sep 2025 Issue date: 22 Feb 2022 | 5 Sep 2018 | 22 Feb 2022 |
| Utility: Covalent diabodies and uses thereof Filling date: 8 Sep 2025 Issue date: 22 Feb 2022 | 5 Mar 2018 | 22 Feb 2022 |
| Utility: ADAM9-binding molecules, and methods of use thereof Filling date: 8 Sep 2025 Issue date: 8 Feb 2022 | 21 Dec 2017 | 8 Feb 2022 |
| Utility: Combination therapy for the treatment of cancer Filling date: 8 Sep 2025 Issue date: 16 Nov 2021 | 6 Oct 2016 | 16 Nov 2021 |
| Utility: CD3-binding molecules capable of binding to human and non-human CD3 Filling date: 8 Sep 2025 Issue date: 7 Sep 2021 | 23 Oct 2018 | 7 Sep 2021 |
| Utility: Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof Filling date: 8 Sep 2025 Issue date: 24 Aug 2021 | 13 Nov 2018 | 24 Aug 2021 |
| Utility: Fc.gamma.RIIB-specific antibodies and methods of use thereof Filling date: 8 Sep 2025 Issue date: 24 Aug 2021 | 6 Sep 2018 | 24 Aug 2021 |
| Utility: Combination therapy for the treatment of cancer Filling date: 8 Sep 2025 Issue date: 3 Aug 2021 | 9 Jun 2016 | 3 Aug 2021 |
| Utility: LAG-3-binding molecules and methods of use thereof Filling date: 8 Sep 2025 Issue date: 27 Jul 2021 | 7 Jun 2016 | 27 Jul 2021 |
| Utility: HER2/neu-specific antibodies and methods of using same Filling date: 8 Sep 2025 Issue date: 8 Jun 2021 | 10 Oct 2018 | 8 Jun 2021 |
| Utility: B7-H3 binding molecules, antibody drug conjugates thereof and methods of use thereof Filling date: 8 Sep 2025 Issue date: 30 Mar 2021 | 13 Apr 2017 | 30 Mar 2021 |
| Utility: Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof Filling date: 8 Sep 2025 Issue date: 23 Mar 2021 | 12 Dec 2016 | 23 Mar 2021 |
| Utility: Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereof Filling date: 8 Sep 2025 Issue date: 8 Dec 2020 | 21 Nov 2017 | 8 Dec 2020 |
| Utility: Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof Filling date: 8 Sep 2025 Issue date: 24 Nov 2020 | 18 Feb 2019 | 24 Nov 2020 |
| Utility: Compound targeting IL-23A and TNF-alpha and uses thereof Filling date: 8 Sep 2025 Issue date: 6 Oct 2020 | 1 Aug 2018 | 6 Oct 2020 |
| Utility: Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereof Filling date: 8 Sep 2025 Issue date: 29 Sep 2020 | 12 Oct 2017 | 29 Sep 2020 |
| Utility: Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof Filling date: 8 Sep 2025 Issue date: 4 Aug 2020 | 24 Jan 2018 | 4 Aug 2020 |
| Utility: Antibodies reactive with B7-H3 and users thereof Filling date: 8 Sep 2025 Issue date: 4 Aug 2020 | 4 Jan 2018 | 4 Aug 2020 |
| Utility: Bispecific molecules comprising an HIV-1 envelope targeting arm Filling date: 8 Sep 2025 Issue date: 21 Jul 2020 | 29 Sep 2015 | 21 Jul 2020 |
| Utility: Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for Fc.gamma.R.sub.activating and Fc.gamma.R.sub.inhibiting Filling date: 8 Sep 2025 Issue date: 14 Jul 2020 | 13 Jun 2017 | 14 Jul 2020 |
| Utility: Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof Filling date: 8 Sep 2025 Issue date: 16 Jun 2020 | 19 Jun 2017 | 16 Jun 2020 |
| Utility: Multi-chain polypeptide-containing tri-specific binding molecules Filling date: 8 Sep 2025 Issue date: 12 May 2020 | 29 May 2015 | 12 May 2020 |
| Utility: Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof Filling date: 8 Sep 2025 Issue date: 28 Apr 2020 | 22 Sep 2015 | 28 Apr 2020 |
| Utility: Multi-chain polypeptide-containing tri-specific binding molecules that specifically bind to multiple cancer antigens Filling date: 8 Sep 2025 Issue date: 28 Apr 2020 | 29 May 2015 | 28 Apr 2020 |
| Utility: PD-1-binding molecules and methods of use thereof Filling date: 8 Sep 2025 Issue date: 3 Mar 2020 | 28 Jul 2016 | 3 Mar 2020 |
| Utility: Multivalent molecules comprising DR5-binding domains Filling date: 8 Sep 2025 Issue date: 10 Dec 2019 | 29 May 2015 | 10 Dec 2019 |
| Utility: BCR-complex-specific antibodies and methods of using same Filling date: 8 Sep 2025 Issue date: 19 Nov 2019 | 31 May 2017 | 19 Nov 2019 |
